Weight Loss

Captide Labs offers research peptides for weight loss and metabolic studies in precision-dosed capsule format. The compounds in this category — Orforglipron, BAM-15, 5-Amino-1MQ, and Tesofensine — represent some of the most actively researched mechanisms in contemporary weight loss research, spanning oral GLP-1 receptor agonism, mitochondrial uncoupling, NNMT inhibition, and triple monoamine reuptake inhibition.

Each weight loss research peptide in our catalog is supplied as a precision-filled oral capsule with verified identity and dose, eliminating the variability of manual reconstitution. Every batch is independently verified by Ethos Laboratories — an ISO 17025–accredited third-party facility — with the full Certificate of Analysis published on each product page.

If you’re investigating oral peptide pathways for weight management research, the capsule format makes consistent dosing protocols significantly easier to maintain than traditional vial-and-syringe formats. All Captide Labs weight loss research peptides are sold strictly for research and laboratory use only — not for human or animal consumption.

Weight Loss Research Peptides — FAQ

What are weight loss research peptides? Research-grade compounds studied in laboratory and preclinical models for pathways linked to appetite regulation, energy expenditure, and metabolism — including GLP-1 receptor agonists (orforglipron), mitochondrial uncouplers (BAM-15), NNMT inhibitors (5-Amino-1MQ), and triple monoamine reuptake inhibitors (tesofensine). They are supplied strictly for research use only and are not weight-loss drugs or supplements.

Which weight loss peptides does Captide Labs offer in capsule form? This category includes Orforglipron, Tesofensine, BAM-15, 5-Amino-1MQ, and SLU-PP-332 — each supplied as a precision-filled oral capsule with a documented Certificate of Analysis for identity, purity, and assay.

Are these oral peptides for weight loss research? Several compounds here are studied in oral form. Orforglipron is a non-peptidic oral GLP-1 receptor agonist, and the capsule format delivers a verified, stated dose without the variability of manual reconstitution. All products remain for laboratory and research use only.

How are purity and identity verified? Every batch is independently tested by Ethos Laboratories, an ISO 17025–accredited third-party facility, to a minimum purity of >98%, with the full Certificate of Analysis published on each product page.